🐋 CRWV: Someone Just Spent $3.9M to Unwind a Deep LEAP Call Position — What Do They Know?

📅 March 4, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

A $3.9M options trade just hit the tape on CoreWeave — someone bought back 1,000 deep LEAP calls at the $100 strike expiring in December 2028, closing out a short call position they had on. This comes as CRWV trades at ~$80 and continues to bleed after a brutal post-earnings selloff that wiped ~25% off the stock in under a week. With the stock down 60% from its highs, a securities fraud lawsuit heating up, and $30-35B in capex plans that have Wall Street divided, this position unwind tells a story worth unpacking.

---

🏢 Company Overview

CoreWeave, Inc. (NASDAQ: CRWV) is a cloud infrastructure company that offers the CoreWeave Cloud Platform — proprietary software and cloud services built to deliver the automation and efficiency needed to manage complex AI infrastructure at scale. Think of them as the pick-and-shovel play for the AI gold rush, renting out massive GPU clusters to hyperscalers and AI companies.

📊 Key Stats:

• 💰 Market Cap: ~$38.5B
• 🏷️ Industry: Prepackaged Software (Services)
• 📅 IPO Date: March 28, 2025 at $40/share
• 🌐 Headquarters: Livingston, NJ
• 🔗 coreweave.com

---

💰 The Option Flow Breakdown

📊 What Just Happened

🤓 What This Actually Means

Let me break this down in plain English.

Someone previously sold these $100 calls — collecting premium by betting that CRWV wouldn't blast past $100 within the next ~3 years. Now they're buying them back at $39.30 each, spending $3.9M to close the position.

Why would someone do this? A few possibilities:

🔑 Scenario 1 — Taking Profits: If they originally sold these calls at a higher price (say, when CRWV was trading near its $187 high), the calls would have been worth significantly more. As the stock cratered to $80 and those calls lost value, they're locking in gains by buying them back cheaper. Classic "take chips off the table" move.

🔑 Scenario 2 — Risk Management: With the stock down 60% from highs and a tsunami of catalysts coming (lawsuits, conferences, potential capital raises), they may not want the exposure of being short calls on a name that could rip higher on any positive news.

🔑 Scenario 3 — Covered Call Unwind: If this was part of a covered call strategy (owning shares + selling calls against them), unwinding the short calls frees them up to sell the underlying shares — or to re-establish calls at different strikes.

The Z-score of 8.38 is eye-catching. Volume of 1,000 contracts exceeded the entire open interest of 913, meaning this single trade basically dominated the entire options chain at this strike and expiration. That kind of activity shows up maybe a few times per quarter — it's not something retail traders typically generate. This is institutional-scale repositioning.

---

📈 Technical Setup / Chart Check-Up

CRWV is in a full-blown downtrend right now. The stock is trading below every major moving average, and post-earnings selling pressure has been relentless.

YTD Chart

The year-to-date picture tells the story of a stock that rallied hard into earnings and then got absolutely hammered on the Q4 report. From near $100 pre-earnings to the low $70s in less than a week — that's a lot of pain in a very short time.

Key takeaway from the chart: the stock broke below its 50-day EMA (~$87) on the earnings gap down and hasn't looked back. The next major support zone is $65-70, which represents late-2025 lows.

---

🔵🟠 Gamma-Based Support & Resistance Analysis

The gamma exposure chart shows where market makers have the most options exposure, which creates natural magnets and barriers for price.

Key Gamma Levels:

The $70 strike sitting at max gamma is important — the stock tested $70.37 intraday today. That's where market makers hold the most exposure, and it often acts like a gravitational pull. Think of it as a "sticky floor" that the stock doesn't want to break through easily.

For CRWV to recover, bulls need to push through $75 first, then reclaim the $86-87 zone (50-day EMA and NVIDIA's buy-in price). That's a tall order in the current environment.

---

📐 Implied Move Analysis

The options market is pricing in significant volatility for CRWV across timeframes:

A ±14.1% implied move through March OpEx is massive. The market is essentially saying: "This stock could be anywhere from $69 to $91 by March 20." That's a $22 range on an $80 stock. The weekly implied move of ±5.8% is also elevated, reflecting the ongoing uncertainty.

For context, March 20 is Triple Witching — quarterly options, index futures, and stock futures all expire on the same day. Add that to CRWV's already-elevated volatility, and you've got a recipe for big swings.

---

🎪 Catalysts

⏰ Upcoming Events

📰 Recent Events (Already Happened)

🔴 Q4 2025 Earnings Miss (Feb 26): Revenue of $1.57B slightly beat but EPS came in at -$0.89 vs -$0.49 consensus — a $0.40 miss. Q4 net loss was $452M. Stock dropped ~20% in a single session. Full earnings details from CNBC

🔴 Sticker Shock on 2026 Capex (Feb 26): CoreWeave guided 2026 capex to $30-35B — more than double the $14.9B spent in 2025. Q1 revenue guidance of $1.9-2.0B was also below the $2.29B consensus. Yahoo Finance breakdown

🔴 CEO Defends Spending (Feb 27): CEO Mike Intrator pushed back against the "debt narrative," arguing that contracted demand justifies the spending and delays would cost more than the upfront investment. CNBC interview

⚖️ Securities Fraud Lawsuits (Feb-March): Multiple law firms filed class actions alleging CoreWeave overstated its scaling capabilities and concealed critical delays at the Denton, Texas data center.

🔴 Insider Selling: Executives dumped $379M worth of shares over the last 3 months — 4.4M shares sold, many within days of vesting. Not exactly a vote of confidence.

🟢 NVIDIA's $2B Investment (Jan 2026): NVIDIA put up $2B at $87.20/share, essentially backstopping its most critical cloud partner. CRWV now trades well below NVIDIA's entry price.

---

🎲 Price Targets & Probabilities

Based on the gamma levels, implied move data, and current catalyst environment, here's how the scenarios break down:

📈 Bull Case — $87-$91 (20% probability near-term)

✅ Stock reclaims the 50-day EMA at ~$87, which also happens to be NVIDIA's buy-in price ✅ Falls within the upper bound of the monthly implied move ($91.39) ✅ Would require positive management commentary at conferences this week or a bullish hyperscaler spending signal ✅ Analyst consensus PT sits at $124 — plenty of room above if sentiment turns

⚖️ Base Case — $70-$80 (55% probability near-term)

✅ Stock chops between the max gamma level ($70) and current price area ($80) ✅ The $75 gamma level acts as a midpoint magnet ✅ March OpEx on the 20th could pin the stock in this range ✅ Continued uncertainty keeps a lid on upside while the gamma floor at $70 limits downside

📉 Bear Case — $60-$65 (25% probability near-term)

❗ A break below the $70 gamma floor opens the door to the $60-65 support zone (late-2025 lows) ❗ Could be triggered by: negative conference commentary, lawsuit escalation, or a surprise capital raise announcement ❗ Lower bound of implied move range lands at $68.86 for March OpEx ❗ Below $65, the next real floor is $40 (IPO price) — that would be a full round trip

---

💡 Trading Ideas

🛡️ Conservative — "The Patience Play" (Cash-Secured Put Sell)

Strategy: Sell the CRWV $65 Put, 2026-04-17 expiration

📊 Why this works: You're getting paid to wait. The $65 level represents late-2025 support and sits well below the current $70 gamma floor. If assigned, you'd own CRWV at an effective cost basis below where the securities fraud lawsuit says insiders were misleading — and well below NVIDIA's $87.20 entry.

⚠️ Risk: CRWV is a high-volatility name. If there's a capital raise or sector-wide AI selloff, $65 could get breached. Requires ~$6,500 in capital per contract as collateral.

🎯 Ideal for: Premium collectors who want exposure to CRWV but only at distressed prices. Let elevated IV work in your favor.

---

⚖️ Balanced — "The Post-Storm Bounce" (Bull Call Spread)

Strategy: Buy the CRWV $80 Call / Sell the $95 Call, 2026-05-15 expiration

📊 Why this works: This captures upside through Q1 earnings (est. May 13-20) while capping your risk. The $80 strike is near current price, and $95 is just below the pre-earnings level. If management delivers at the conferences and Q1 earnings show capex execution, this spread could pay handsomely. Max profit at $95+, max loss limited to the debit paid.

⚠️ Risk: Time decay works against you, and CRWV needs to move higher — not just stay flat. If the stock continues grinding lower into earnings, the spread expires worthless.

🎯 Ideal for: Swing traders who think the selloff is overdone and want a defined-risk way to play the recovery into Q1 earnings.

---

🚀 Aggressive — "The NVIDIA Backstop Bounce" (Long Calls)

Strategy: Buy the CRWV $85 Call, 2026-06-19 expiration

📊 Why this works: NVIDIA bought in at $87.20, and every analyst except one has a Buy rating with an average PT of $124. If the AI capex cycle stays intact through hyperscaler earnings in April, CRWV could reclaim its pre-earnings range. The June expiration gives you time for multiple catalyst events — conferences (March), lawsuit deadline (March 13), hyperscaler earnings (April), and Q1 results (May).

⚠️ Risk: Options are expensive right now — implied vol is elevated. You're fighting the downtrend and paying up for premium. If the stock stays below $85 through June, you lose your entire investment. Only use capital you can afford to lose.

🎯 Ideal for: Traders with high conviction that the selloff is a buying opportunity and that CRWV's $66.8B backlog will eventually be reflected in the stock price.

---

⚠️ Risk Factors

❗ Debt Mountain: CoreWeave carries $14B+ in debt with $34B in lease obligations through 2028. A $4.2B principal repayment is due later this year. If capital markets tighten, this becomes an existential problem.

❗ Customer Concentration: Microsoft accounts for ~67% of revenue. That's one customer holding the keys to the kingdom. Microsoft is also a direct competitor in cloud — monopsony risk is real.

❗ Execution Risk: The $30-35B capex plan requires near-perfect execution. The Denton data center delays already proved that third-party dependencies can derail timelines.

❗ Securities Litigation: Multiple class actions are progressing with a March 13 lead plaintiff deadline. While rarely existential, lawsuits create headline risk and management distraction.

❗ Insider Selling: $379M in insider sales over 3 months. When the people running the company are aggressively reducing exposure, retail traders should take notice.

❗ AI Capex Cycle Risk: If hyperscaler spending decelerates or the AI investment-to-revenue gap triggers a pullback, CoreWeave's contracted backlog could face renegotiation pressure.

❗ Dilution Risk: Given the massive capex plan, additional debt or equity raises are virtually certain. Any equity offering would dilute existing shareholders.

---

🎯 The Bottom Line

Real talk: This $3.9M LEAP call unwind is institutional housekeeping — someone with a big position is tidying up their book as CRWV enters a gauntlet of catalysts. The trade itself isn't screaming "buy" or "sell" — it's someone managing risk around a position that got complicated after a 25% post-earnings crash.

Here's your action plan:

📊 If you're bullish: Wait for the stock to stabilize above $70 and ideally reclaim $75 before jumping in. The Morgan Stanley conference today at 4:05 PM ET and the Cantor conference on March 10 are the next inflection points. A bull call spread into May earnings (like the Balanced idea above) gives you defined risk with multiple catalysts ahead.

👀 If you're on the sidelines: This is probably the right place to be. CRWV has a catalyst density score of 9/10 — between lawsuits, conferences, hyperscaler earnings, and its own Q1 report, there are binary events every few weeks through May. Let the dust settle, and look for entries if the stock holds $70 support or breaks above $87.

🐻 If you're bearish: The $70 gamma floor is your key level. A decisive break below opens the door to $60-65, and the put/call open interest ratio of 1.46 (more puts than calls in positioning) suggests you're not alone in that view. Just be careful — short interest at 9.7% means a squeeze is always possible on any positive headline.

📅 Mark your calendar: March 4 (Morgan Stanley Conference — TODAY), March 10 (Cantor Conference), March 13 (lawsuit deadline), March 20 (Triple Witch OpEx), and May 13-20 (Q1 Earnings).

The bottom line on the flow: a $3.9M position unwind on a stock that's down 60% from highs, with a Z-score that puts this in the top tier of unusual activity. Institutional players are repositioning. Whether they're locking in profits from a well-timed short call or cutting risk ahead of more turbulence, the message is clear — the smart money is actively managing CRWV exposure, and you should be too.

---

⚠️ Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Options trading involves significant risk of loss and is not suitable for all investors. Always do your own research and consider your risk tolerance before placing any trades. Past performance does not guarantee future results.